Clinical and biological heterogeneity in acute respiratory distress syndrome: Direct versus indirect lung injury

Clinics in Chest Medicine

Volumn 35, Issue 4, 2014, Pages 639-653

  Shaver, Ciara M ^a   Bastarache, Julie A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Direct lung injury; Indirect lung injury

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOPOIETIN 2; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN C2; BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LUNG SURFACTANT; METHYLPREDNISOLONE; MUCIN 1; VON WILLEBRAND FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; BREATHING MECHANICS; CELL TRANSPORT; CLINICAL EFFECTIVENESS; CYTOKINE PRODUCTION; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG RESPONSE; EXPERIMENTAL DESIGN; GENETIC RISK; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INFLAMMATORY CELL; LUNG ALVEOLUS; LUNG BIOPSY; LUNG CAPACITY; LUNG INJURY; LYMPHOCYTE FUNCTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR PATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PNEUMONIA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYNDROME DELINEATION; T LYMPHOCYTE; THORAX RADIOGRAPHY; TISSUE CHARACTERIZATION; ACUTE LUNG INJURY; ANIMAL; DISEASE MODEL; PATHOPHYSIOLOGY;

ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS;

EID: 84909579961     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2014.08.004     Document Type: Review

References (86)

1. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149(3 Pt 1):818-824.
2. Peres e Serra A., Parra E.R., Eher E., et al. Nonhomogeneous immunostaining of hyaline membranes in different manifestations of diffuse alveolar damage. Clinics (Sao Paulo) 2006, 61(6):497-502.
3. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. NEngl J Med 2000, 342(18):1334-1349.
4. Rubenfeld G.D., Caldwell E., Peabody E., et al. Incidence and outcomes of acute lung injury. NEngl J Med 2005, 353(16):1685-1693.
5. Brun-Buisson C., Minelli C., Bertolini G., et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 2004, 30(1):51-61.
6. Capelozzi V.L. What have anatomic and pathologic studies taught us about acute lung injury and acute respiratory distress syndrome?. Curr Opin Crit Care 2008, 14(1):56-63.
7. Hoelz C., Negri E.M., Lichtenfels A.J., et al. Morphometric differences in pulmonary lesions in primary and secondary ARDS. A preliminary study in autopsies. Pathol Res Pract 2001, 197(8):521-530.
8. Negri E.M., Hoelz C., Barbas C.S., et al. Acute remodeling of parenchyma in pulmonary and extrapulmonary ARDS. An autopsy study of collagen-elastic system fibers. Pathol Res Pract 2002, 198(5):355-361.
9. Lamy M., Fallat R.J., Koeniger E., et al. Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. Am Rev Respir Dis 1976, 114(2):267-284.
10. Desai S.R., Wells A.U., Suntharalingam G., et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary injury: a comparative CT study. Radiology 2001, 218(3):689-693.
11. Goodman L.R., Fumagalli R., Tagliabue P., et al. Adult respiratory distress syndrome due to pulmonary and extrapulmonary causes: CT, clinical, and functional correlations. Radiology 1999, 213(2):545-552.
12. Pelosi P., D'Onofrio D., Chiumello D., et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl 2003, 42:48s-56s.
13. Winer-Muram H.T., Steiner R.M., Gurney J.W., et al. Ventilator-associated pneumonia in patients with adult respiratory distress syndrome: CT evaluation. Radiology 1998, 208(1):193-199.
14. Rouby J.J., Puybasset L., Cluzel P., et al. Regional distribution of gas and tissue in acute respiratory distress syndrome. II. Physiological correlations and definition of an ARDS severity score. CT Scan ARDS Study Group. Intensive Care Med 2000, 26(8):1046-1056.
15. Gattinoni L., Pelosi P., Suter P.M., et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?. Am J Respir Crit Care Med 1998, 158(1):3-11.
16. Pelosi P., Brazzi L., Gattinoni L. Prone position in acute respiratory distress syndrome. Eur Respir J 2002, 20(4):1017-1028.
17. Lim C.M., Jung H., Koh Y., et al. Effect of alveolar recruitment maneuver in early acute respiratory distress syndrome according to antiderecruitment strategy, etiological category of diffuse lung injury, and body position of the patient. Crit Care Med 2003, 31(2):411-418.
18. Tugrul S., Akinci O., Ozcan P.E., et al. Effects of sustained inflation and postinflation positive end-expiratory pressure in acute respiratory distress syndrome: focusing on pulmonary and extrapulmonary forms. Crit Care Med 2003, 31(3):738-744.
19. Pelosi P., Cadringher P., Bottino N., et al. Sigh in acute respiratory distress syndrome. Am J Respir Crit Care Med 1999, 159(3):872-880.
20. Albaiceta G.M., Taboada F., Parra D., et al. Differences in the deflation limb of the pressure-volume curves in acute respiratory distress syndrome from pulmonary and extrapulmonary origin. Intensive Care Med 2003, 29(11):1943-1949.
21. Tejera P., Meyer N.J., Chen F., et al. Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin. JMed Genet 2012, 49(11):671-680.
22. Gong M.N., Zhou W., Williams P.L., et al. -308GA and TNFB polymorphisms in acute respiratory distress syndrome. Eur Respir J 2005, 26(3):382-389.
23. Chen X., Shan Q., Jiang L., et al. Quantitative proteomic analysis by iTRAQ for identification of candidate biomarkers in plasma from acute respiratory distress syndrome patients. Biochem Biophys Res Commun 2013, 441(1):1-6.
24. Janz D.R., Ware L.B. Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials. Semin Respir Crit Care Med 2013, 34(4):537-548.
25. Uchida T., Shirasawa M., Ware L.B., et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006, 173(9):1008-1015.
26. Ishizaka A., Matsuda T., Albertine K.H., et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004, 286(6):L1088-L1094.
27. Kondo T., Hattori N., Ishikawa N., et al. KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome. Respir Res 2011, 12:32.
28. van der Heijden M., Pickkers P., van Nieuw Amerongen G.P., et al. Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009, 35(9):1567-1574.
29. Calfee C.S., Gallagher D., Abbott J., et al. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med 2012, 40(6):1731-1737.
30. van der Heijden M., van Nieuw Amerongen G.P., Koolwijk P., et al. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008, 63(10):903-909.
31. Parikh S.M., Mammoto T., Schultz A., et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006, 3(3):e46.
32. Rubin D.B., Wiener-Kronish J.P., Murray J.F., et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. JClin Invest 1990, 86(2):474-480.
33. Ong T., McClintock D.E., Kallet R.H., et al. Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med 2010, 38(9):1845-1851.
34. Schmidt E.P., Li G., Li L., et al. The circulating glycosaminoglycan signature of respiratory failure in critically ill adults. JBiol Chem 2014, 289(12):8194-8202.
35. Lim C.M., Kim E.K., Lee J.S., et al. Comparison of the response to the prone position between pulmonary and extrapulmonary acute respiratory distress syndrome. Intensive Care Med 2001, 27(3):477-485.
36. Rialp G., Betbese A.J., Perez-Marquez M., et al. Short-term effects of inhaled nitric oxide and prone position in pulmonary and extrapulmonary acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 164(2):243-249.
37. Spragg R.G., Lewis J.F., Walmrath H.D., et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. NEngl J Med 2004, 351(9):884-892.
38. Anzueto A., Baughman R.P., Guntupalli K.K., et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. NEngl J Med 1996, 334(22):1417-1421.
39. Kesecioglu J., Beale R., Stewart T.E., et al. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2009, 180(10):989-994.
40. Willson D.F., Notter R.H. The future of exogenous surfactant therapy. Respir Care 2011, 56(9):1369-1386. [discussion: 1386-8].
41. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. NEngl J Med 2000, 342(18):1301-1308.
42. Eisner M.D., Thompson T., Hudson L.D., et al. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 164(2):231-236.
43. Monchi M., Bellenfant F., Cariou A., et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 1998, 158(4):1076-1081.
44. Suntharalingam G., Regan K., Keogh B.F., et al. Influence of direct and indirect etiology on acute outcome and 6-month functional recovery in acute respiratory distress syndrome. Crit Care Med 2001, 29(3):562-566.
45. Agarwal R., Aggarwal A.N., Gupta D., et al. Etiology and outcomes of pulmonary and extrapulmonary acute lung injury/ARDS in a respiratory ICU in North India. Chest 2006, 130(3):724-729.
46. Agarwal R., Srinivas R., Nath A., et al. Is the mortality higher in the pulmonary vs the extrapulmonary ARDS? A meta analysis. Chest 2008, 133(6):1463-1473.
47. Parker C.M., Heyland D.K., Groll D., et al. Mechanism of injury influences quality of life in survivors of acute respiratory distress syndrome. Intensive Care Med 2006, 32(11):1895-1900.
48. Schelling G., Stoll C., Vogelmeier C., et al. Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome. Intensive Care Med 2000, 26(9):1304-1311.
49. Orme J., Romney J.S., Hopkins R.O., et al. Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 2003, 167(5):690-694.
50. Herridge M.S. Recovery and long-term outcome in acute respiratory distress syndrome. Crit Care Clin 2011, 27(3):685-704.
51. Herridge M.S., Tansey C.M., Matte A., et al. Functional disability 5 years after acute respiratory distress syndrome. NEngl J Med 2011, 364(14):1293-1304.
52. Dowdy D.W., Eid M.P., Dennison C.R., et al. Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med 2006, 32(8):1115-1124.
53. Matute-Bello G., Downey G., Moore B.B., et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 2011, 44(5):725-738.
54. Su X., Looney M.R., Gupta N., et al. Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am J Physiol Lung Cell Mol Physiol 2009, 297(1):L1-L5.
55. Calfee C.S., Ware L.B., Eisner M.D., et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008, 63(12):1083-1089.
56. Lomas-Neira J., Venet F., Chung C.S., et al. Neutrophil-endothelial interactions mediate angiopoietin-2-associated pulmonary endothelial cell dysfunction in indirect acute lung injury in mice. Am J Respir Cell Mol Biol 2014, 50(1):193-200.
57. Menezes S.L., Bozza P.T., Neto H.C., et al. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. JAppl Physiol (1985) 2005, 98(5):1777-1783.
58. Santos F.B., Nagato L.K., Boechem N.M., et al. Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. JAppl Physiol (1985) 2006, 100(1):98-106.
59. Putensen C., Waibel U., Koller W., et al. Assessment of changes in lung microvascular permeability in posttraumatic acute lung failure after direct and indirect injuries to lungs. Anesth Analg 1992, 74(6):793-799.
60. Ware L.B., Matthay M.A. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163(6):1376-1383.
61. Tauseef M., Knezevic N., Chava K.R., et al. TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation. JExp Med 2012, 209(11):1953-1968.
62. Egli M., Duplain H., Lepori M., et al. Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice. JPhysiol 2004, 560(Pt 3):857-865.
63. Perl M., Lomas-Neira J., Venet F., et al. Pathogenesis of indirect (secondary) acute lung injury. Expert Rev Respir Med 2011, 5(1):115-126.
64. Galani V., Tatsaki E., Bai M., et al. The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract 2010, 206(3):145-150.
65. Reiss L.K., Uhlig U., Uhlig S. Models and mechanisms of acute lung injury caused by direct insults. Eur J Cell Biol 2012, 91(6-7):590-601.
66. Puneet P., Moochhala S., Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005, 288(1):L3-L15.
67. Bhargava R., Janssen W., Altmann C., et al. Intratracheal IL-6 protects against lung inflammation in direct, but not indirect, causes of acute lung injury in mice. PLoS One 2013, 8(5):e61405.
68. Leite-Junior J.H., Garcia C.S., Souza-Fernandes A.B., et al. Methylprednisolone improves lung mechanics and reduces the inflammatory response in pulmonary but not in extrapulmonary mild acute lung injury in mice. Crit Care Med 2008, 36(9):2621-2628.
69. Venet F., Chung C.S., Huang X., et al. Lymphocytes in the development of lung inflammation: a role for regulatory CD4+ T cells in indirect pulmonary lung injury. JImmunol 2009, 183(5):3472-3480.
70. Venet F., Huang X., Chung C.S., et al. Plasmacytoid dendritic cells control lung inflammation and monocyte recruitment in indirect acute lung injury in mice. Am J Pathol 2010, 176(2):764-773.
71. D'Alessio F.R., Tsushima K., Aggarwal N.R., et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. JClin Invest 2009, 119(10):2898-2913.
72. Garibaldi B.T., D'Alessio F.R., Mock J.R., et al. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am J Respir Cell Mol Biol 2013, 48(1):35-43.
73. Xing Z., Gauldie J., Cox G., et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. JClin Invest 1998, 101(2):311-320.
74. Mommsen P., Barkhausen T., Frink M., et al. Productive capacity of alveolar macrophages and pulmonary organ damage after femoral fracture and hemorrhage in IL-6 knockout mice. Cytokine 2011, 53(1):60-65.
75. Gurkan O.U., He C., Zielinski R., et al. Interleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injury. Exp Lung Res 2011, 37(10):575-584.
76. Meduri G.U., Headley S., Kohler G., et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995, 107(4):1062-1073.
77. Parsons P.E., Eisner M.D., Thompson B.T., et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005, 33(1):1-6. [discussion: 230-2].
78. Simmons E.M., Himmelfarb J., Sezer M.T., et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65(4):1357-1365.
79. Meng Z.H., Dyer K., Billiar T.R., et al. Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 2001, 280(2):C343-C351.
80. Riva D.R., Oliveira M.B.G., Rzezinski A.F., et al. Recruitment maneuver in pulmonary and exptrapulmonary experimental acute lung injury. Crit Care Med 2008, 36(6):1900-1908.
81. Kuiper J.W., Plotz F.B., Groeneveld A.J., et al. High tidal volume mechanical ventilation-induced lung injury in rats is greater after acid instillation than after sepsis-induced acute lung injury, but does not increase systemic inflammation: an experimental study. BMC Anesthesiol 2011, 11:26.
82. Yang Y., Chen Q., Liu S., et al. Effects of recruitment maneuvers with PEEP on lung volume distribution in canine models of direct and indirect lung injury. Mol Biol Rep 2014, 41(3):1325-1333.
83. Maron-Gutierrez T., Silva J.D., Asensi K.D., et al. Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice. Crit Care Med 2013, 41(11):e319-e333.
84. Araujo I.M., Abreu S.C., Maron-Gutierrez T., et al. Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury. Crit Care Med 2010, 38(8):1733-1741.
85. Perl M., Chung C.S., Lomas-Neira J., et al. Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol 2005, 167(6):1545-1559.
86. Thakkar R.K., Chung C.S., Chen Y., et al. Local tissue expression of the cell death ligand, fas ligand, plays a central role in the development of extrapulmonary acute lung injury. Shock 2011, 36(2):138-143.